PAVM - PAVmed Inc logo

PAVM

PAVmed Inc

Net โ€”top 1%Rev โ€”top 1%10Y
Hold

PAVmed Inc. develops and commercializes medical devices targeting unmet health needs. Key products include CarpX for carpal tunnel syndrome, EsoCheck for esophageal cancer screening, and PortIO, an implantable vascular access device.

โš•๏ธ Healthcare NASDAQ Listed 2016 $ USD
$1,000 invested 10 years ago โ†’$1today

Score Overview

1 Year
Score
Net Growth-98.99%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-97.63%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth101.17%
Net Trend40%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growthโ€”
Net Trendโ€”
Net Income Consistency
Rev Growthโ€”
Rev Trendโ€”
Revenue Consistency
All Time
Scoreโ€”
Net Growth107.10%
Net Trend33%
Net Income Consistency
Rev Growthโ€”
Rev Trend33%
Revenue Consistency

See the full market ranking โ†’

PAVmed Inc fundamental performance

Across PAVmed Inc's full reported history, from 2016 to 2025, revenue grew from $ 0.00 to $ 71K and net income went from -$ 5M to $ 401K. Revenue increased in 33% of the years measured; net income in 33%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 4.21โ€”
1 Year2025-08-12
$ 13.27-68.26%
5 Years2021-08-12
$ 2.84K-99.85%
10 Years2016-08-10
$ 5.3K-99.92%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 71K$ 401K$ 1.53B
2024$ 2M$ 39M$ 1M
2023$ 2M-$ 64M$ 19M
2022$ 377K-$ 88M$ 42M
2021$ 500K-$ 50M$ 79M
2020$ 0.00-$ 34M$ 17M
2019$ 0.00-$ 15M$ 6M
2018$ 0.00-$ 17M$ 8M
2017$ 0.00-$ 9M$ 1M
IPO2016$ 0.00-$ 5M$ 585.68K

Explore beyond PAVM

You're looking at PAVmed Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies